NCT06424548View on ClinicalTrials.gov

Comparison of the Improvement and Safety of the Ankle Brachial Arterial Pressure Index of Sarpogrelate and Clopidogrel in Stroke Patients With Decreased Ankle Brachial Arterial Pressure Index and Intermittent Claudication of Lower Limb Vascular Atherosclerosis.

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 16, 2024

Primary Completion Date

June 30, 2028

Study Completion Date

December 31, 2028

Conditions
StrokeAtherosclerosis
Interventions
DRUG

Administration of Sarpogrelate

Aspirin 100mg plus Sarpogrelate 100mg

DRUG

Traditional administration of Clopidogrel

Aspirin 100mg plus Clopidogrel 75mg

All Listed Sponsors
lead

Ewha Womans University Seoul Hospital

OTHER

NCT06424548 - Comparison of the Improvement and Safety of the Ankle Brachial Arterial Pressure Index of Sarpogrelate and Clopidogrel in Stroke Patients With Decreased Ankle Brachial Arterial Pressure Index and Intermittent Claudication of Lower Limb Vascular Atherosclerosis. | Biotech Hunter | Biotech Hunter